Vaccines, blood, antisera, toxins and cultures in   Qatar

Exports In 2022, Qatar exported $47.9M in Vaccines, blood, antisera, toxins and cultures, making it the 50th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 31st most exported product in Qatar. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Qatar are: Oman ($44.2M), South Korea ($3.34M), Denmark ($107k), Chile ($53.2k), and United States ($49.3k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Qatar between 2021 and 2022 were Oman ($12.7M), South Korea ($3.33M), and Denmark ($107k).

Imports In 2022, Qatar imported $328M in Vaccines, blood, antisera, toxins and cultures, becoming the 63rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 17th most imported product in Qatar. Qatar imports Vaccines, blood, antisera, toxins and cultures primarily from: Spain ($79.3M), Belgium ($64.6M), United States ($52.7M), Switzerland ($45.3M), and Germany ($20.1M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Qatar between 2021 and 2022 were United States ($30.1M), Switzerland ($8.06M), and United Arab Emirates ($8.02M).